Singapore markets close in 43 minutes
Straits Times Index
3,262.50 -37.54 (-1.14%) Nikkei
38,202.37 -632.73 (-1.63%) Hang Seng
18,331.76 -147.61 (-0.80%) FTSE 100
8,347.89 +34.22 (+0.41%) Bitcoin USD
62,194.12 -1,319.15 (-2.08%) CMC Crypto 200
1,288.39 -6.29 (-0.49%)
AXSM Jun 2024 92.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:54PM EDT. Market open.
| Previous close | 16.11 |
| Open | 16.11 |
| Bid | 19.00 |
| Ask | 23.40 |
| Strike | 92.50 |
| Expiry date | 2024-06-21 |
| Day's range | 16.11 - 16.11 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksAxsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
Axsome's (AXSM) bottom line declines year over year in the first quarter. Strong sales of Auvelity drive revenues.
Insider MonkeyAxsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript May 6, 2024 Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.44233 EPS, expectations were $-1.2. Axsome Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
- GuruFocus.com
Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...
Discover how Axsome Therapeutics achieved a 160% revenue increase and navigated heightened R&D and operational costs in Q1 2024.
© 2024 Yahoo. All rights reserved.